You are viewing the site in preview mode
Skip to main content
|
Variables
|
Pre-HIFU
|
Pre-sRARP
|
Final sRARP pathology
|
|---|
|
Age, years (IQR)
|
62 (IQR 60–66)
|
63.0 yrs. (IQR 61–66)
|
–
|
|
PSA, median (IQR)
|
7.3 (5.5–8.9)
|
6 (3.9–10.0)
|
–
|
|
Gleason score, n (%):
|
|
3 + 3
|
9 (20.0)
|
3 (6.7)
|
0 (0)
|
|
3 + 4
|
29 (64.4)
|
22 (48.9)
|
22 (48.9)
|
|
4 + 3 (or 3 + 4 with tertiary grade 5)
|
5 (11.1)
|
15 (33.3)
|
18 (40.0)
|
|
4 + 4 (or 4 + 3 with tertiary grade 5)
|
2 (4.4)
|
2 (4.4)
|
1 (2.2)
|
|
4 + 5
|
–
|
3 (6.7)
|
4 (8.9)
|
|
T-stage*, n (%):
|
|
T2
|
43 (95.6)
|
40 (88.9)
|
16 (35.6)
|
|
T3a
|
2 (4.4)
|
4 (8.9)
|
21 (46.7)
|
|
T3b
|
–
|
1 (2.2)
|
8 (17.8)
|
|
Max cancer core length in mm, median (IQR)
|
7 (5–10)
|
6 (3–8)
|
n/a
|
|
Number of cores taken, median (IQR)
|
36 (14–58)
|
13 (8–24)
|
n/a
|
|
Percentage of positive cores, median (IQR)
|
17 (11–30)
|
30 (14–40)
|
n/a
|
